Skip to main content

Table 3 Cox proportional hazards models for recurrence

From: Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

   Univariate analysis Multivariate analysis Multivariate analysis
   HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Sex Male 2.53 (1.16–5.52) 0.0200 1.99 (0.90–4.42) 0.0913 2.00 (0.91–4.40) 0.0876
Age ≥ 70 years 2.80 (1.36–5.77) 0.0054 3.06 (1.48–6.34) 0.0028 2.79 (1.35–5.75) 0.0056
Tumor size > 3 cm 1.99 (1.04–3.81) 0.0380     
pN + 3.20 (1.51–6.77) 0.0025     
Stage ≥ IB 2.54 (1.30–4.99) 0.0070 2.16 (1.08–4.31) 0.0306 2.23 (1.13–4.43) 0.0222
Histology SCC 1.23 (0.62–2.44) 0.5567     
CDK1SA ≥ 12.6 2.26 (1.16–4.43) 0.0177 2.25 (1.14–4.42) 0.0195   
CDK2SA ≥ 222 1.82 (0.93–3.56) 0.0837    1.53 (0.79–3.01) 0.2165